IGC Pharma, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
IGC Pharma, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2023.
  • IGC Pharma, Inc. Operating Lease, Payments for the quarter ending June 30, 2022 was $26K, a 3.7% decline year-over-year.
  • IGC Pharma, Inc. annual Operating Lease, Payments for 2023 was $140K, a 18.6% increase from 2022.
  • IGC Pharma, Inc. annual Operating Lease, Payments for 2022 was $118K, a 8.26% increase from 2021.
  • IGC Pharma, Inc. annual Operating Lease, Payments for 2021 was $109K, a 38% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $140K +$22K +18.6% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-24
2022 $118K +$9K +8.26% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-24
2021 $109K +$30K +38% Apr 1, 2021 Mar 31, 2022 10-K 2023-07-07
2020 $79K +$69K +690% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-23
2019 $10K Apr 1, 2019 Mar 31, 2020 10-K 2021-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.